GlassScriptPhysician profile
Antonela Svetic
NPI 1245309384
$6,223.85
in general payments reported to CMS, 2019-2025
48 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $404 · 2021: $1,036 · 2022: $1,191 · 2023: $943 · 2024: $912 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,219.93 | 2021-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $695.62 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $502.17 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $396.76 | 2021 | |
| Eisai INC. | $334.19 | 2019-2025 | |
| Allergan, INC. | $294.41 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $276.27 | 2019-2024 | |
| Mdd US Operations, LLC | $272.32 | 2022-2024 | Gocovri, Gocovri |
| Genentech USA, INC. | $247.07 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Medtronic, INC. | $188.28 | 2021-2024 | Mycarelink, Azure Xt Dr Mri Surescan |
| Neuronetics, INC. | $170.54 | 2022 | |
| Sunovion Pharmaceuticals INC. | $165.77 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $143.61 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $132.94 | 2019-2021 | |
| Amgen INC. | $131.34 | 2019-2020 |
Show all 47 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonela Svetic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.